Status:
COMPLETED
Adherence Monitoring in Ambulatory Hypertensive Patients
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Hypertension is a major risk factor for stroke, ischaemic heart disease, and kidney disease. One major cause for uncontrolled blood pressure in spite of prescribed pharmacotherapy was found to be non-...
Detailed Description
Patients with hypertension are usually asymptomatic and do not feel an immediate benefit when taking their medication. This can result in early treatment interruption, omitted doses or drug holidays. ...
Eligibility Criteria
Inclusion
- Patients with the following inclusion criteria will be recruited:
- is ≥18 years old;
- is diagnosed with arterial hypertension;
- is prescribed at least 1 antihypertensive medication;
- self-administers medication;
- is suspected of a deviant medication intake behavior (non-adherence) e.g., because of insufficiently controlled blood pressure in spite of prescribed pharmacotherapy (nonresponding);
- accepts to use of an electronic monitoring device during the study period (either the Time4Med™ device or the monitoring app busybee™);
- signs the informed consent form;
- understands and speaks German.
- Patients who are using a pillbox, an app or reminders for medication management will not be excluded.
Exclusion
- Patients who are, in the opinion of the GP, unlikely to comply with the study schedule or are unsuitable for any other reason will be excluded.
Key Trial Info
Start Date :
February 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 17 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05215652
Start Date
February 15 2022
End Date
April 17 2023
Last Update
April 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Praxis Hammer
Basel, Switzerland, 4057